Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

University of Washington at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

University of Washington brings 27 presentations to ASH 2026 in New Orleans. Its research spans transplant studies and blood biology across leukemia and clotting. It covers a phase I trial of decoy-resistant IL-18 after allogeneic stem cell transplant and ctDNA-based residual disease in follicular lymphoma.

OrganizationASH 2026 Attendance
Universities & research institutes
Public research university in Seattle with UW Medicine and a cancer partnership with Fred Hutch.
Talk
Mon Dec 14
10:30am–11:45am
Decoding the Mysteries of the VWF Gene
Long-read sequencing to resolve complex variation in the gene for a major blood-clotting protein, and its promise as a first-line diagnostic test.
Clotting · Blood biology

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Washington

Tell us what you sell and we’ll find the people at University of Washington most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction